Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microfluidic-based diagnostics for cervical cancer cells.

Z Du1, N Colls, K H Cheng

  • 1Biological Sciences, Texas Tech University, MS 3131, Lubbock, TX 79409, USA.

Biosensors & Bioelectronics
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leaf to Root: Harnessing leaf spectral signatures for non-destructive monitoring of soybean nodule traits.

Plant phenomics (Washington, D.C.)·2026
Same author

Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.

Stem cell research & therapy·2025
Same author

Ultrasound-based ADNEX model for differentiating between benign, borderline, and malignant epithelial ovarian tumours.

Clinical radiology·2024
Same author

Differential pathogenicity and lethality of bubonic plague (1720-1945) by sex, age and place.

Proceedings. Biological sciences·2024
Same author

Synergistic controls of water column stability and groundwater phosphate on coastal algal blooms.

Water research·2024
Same author

Clinical, imaging, and pathological characteristics of congenital infiltrating lipomatosis of the face.

International journal of oral and maxillofacial surgery·2024
Same journal

AI-driven photophysics-aware design of fluorescent probes with applications in α-synuclein biosensing and inhibitor screening.

Biosensors & bioelectronics·2026
Same journal

Three-dimensional helical integration of high-density linear microelectrode arrays and their cross-tissue applications.

Biosensors & bioelectronics·2026
Same journal

Integration of electrochemical sensors in organ-on-a-chip microfluidic platforms: Advances and perspectives.

Biosensors & bioelectronics·2026
Same journal

DNN-PURE: A deep neural network approach to paper-based urea sensing.

Biosensors & bioelectronics·2026
Same journal

Rationally architected MOF-derived Co<sub>3</sub>O<sub>4</sub>@NiMn-LDH hollow heterostructure-based sensor array empowering sensitive detection and discrimination of neurological biomarkers.

Biosensors & bioelectronics·2026
Same journal

Four-in-one multifunctional CoCu-NC@AuPt nanozyme integrated M13 phage-displayed nanobody based multimodal lateral flow immunoassay for bovine lactoferrin detection.

Biosensors & bioelectronics·2026
See all related articles

This study presents a microfluidics platform using alpha6-integrin antibodies to capture cervical cancer cells. The technology shows promise for sensitive and accurate detection of cervical cancer and similar malignancies.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Cell Biology

Background:

  • Biomarker discovery for tumor cell detection is advancing rapidly.
  • Clinical application of these biomarkers lags behind their availability.
  • Cervical cancer detection requires improved sensitive and accurate technologies.

Purpose of the Study:

  • To develop an antibody-based microfluidics platform for recognizing and capturing cervical cancer cells.
  • To utilize alpha6-integrin as a specific capture target due to its correlation with HPV-16 infection.
  • To assess the platform's efficacy in distinguishing cervical cancer cells from normal cell types.

Main Methods:

  • An antibody-based microfluidics system was designed with alpha6-integrin antibodies immobilized on the channel surface.

Related Experiment Videos

  • Suspensions of normal human glandular epithelial cells (HGEC), human cervical stromal cells (HCSC), and cervical cancer cells (HCCC) were prepared in PBS.
  • These cell suspensions were flowed through the microfluidics platform for capture analysis.

    • Main Results:

    • The microfluidics platform successfully captured over 30% of cervical cancer cells (HCCC).
    • Capture of normal cell types (HGEC and HCSC) was significantly lower, less than 5%.
    • The developed technique demonstrated high sensitivity and accuracy in cell capture.

    Conclusions:

    • The antibody-based microfluidics platform is a sensitive and accurate method for cervical cancer cell detection.
    • This technology has potential applications in early-stage cervical cancer diagnosis.
    • The platform may be adaptable for detecting other cancers with specific cell surface antigen expression patterns.